Markets
Supporters of both parties exchange words outside CBS Studios ahead of the vice-presidential debate between Gov. Tim Walz (D) and Sen. JD Vance (R-Ohio)
Supporters of Trump/Vance display their sign as a Harris/Walz bus drives past (Ricky Carioti/Getty Images)
Indecision 2024

Massive divergence between US stocks and the stock market’s “fear gauge” as election looms

Traders are taking out insurance against a market-unfriendly result to the November 5 vote even as stocks continue to climb to fresh records.

Luke Kawa

The US election is creating a big disconnect between the performance of the S&P 500 and traders’ most popular gauge for assessing the level of worry among market participants: the VIX.

Typically, when the S&P 500 Index has made an all-time high, the VIX Index — the expected volatility of the benchmark gauge over the next 30 days, often called the market’s “fear gauge” — is at 13.5. Last week, the VIX ended above 20 twice while US stocks set fresh records.

Only 12% of S&P 500 record closes saw a higher VIX than Friday’s close. Nearly all of these instances were during the dot-com bubble or the market’s rapid reclamation of all-time highs after the pandemic struck, though mass uncertainty still reigned over when we’d see life return to normal.

The VIX Index is based on one-month options prices. Usually, its expectations are somewhat extrapolative, hinging on recent history. That is, if the market just had a big down day, people will be more concerned about the potential for the beatings to continue until morale improves. Vice versa if there’s been smooth sailing recently.

Currently, the realized volatility of the S&P 500 over the past month is 10.1 — low by historical standards. High implied volatility right now is not based on extrapolative expectations, but rather, it’s effectively a function of traders taking out insurance, as the results of the election might prove unsettling to the stock market.

“Looking out over the next few weeks, however, the vol premium for the US election is likely to keep moving higher as it has in prior elections,” wrote Deutsche Bank strategists led by Parag Thatte.

Of course, it’s notoriously difficult to say what kind of election outcome would cause the most knee-jerk negative response in markets, or when political changes really leave a market imprint. US equity futures dived as the 2016 election results showed a surprising victory for President Donald Trump, only to turn around and scream higher as traders decided that a world of tax cuts wouldn’t be the worst thing for corporate America and could outweigh any potential negatives. 

Stocks performed well after the 2020 results. But what really began to kick off volatility in the bond market was the run-off Senate election in early 2021 that gave Democrats full control of both legislative bodies of Congress and made it easier to increase government spending.

Dennis DeBusschere, 22V Research chief market strategist, reckons that a divided government will be the most market-friendly outcome for the November 5 vote.

“An orderly election, no sweep, and continued strong economic growth would reduce tail risk concerns, supporting lower implied vol, a risk-on rotation, and higher markets in the final months of 2024,” he wrote.

On that front, expectations are about as much of a coin flip as for the presidential election itself — at least according to betting markets. On Kalshi, the cumulative probability of a Republican or Democratic sweep is marginally higher than any divided-government result.

And while it’s not the usual state of affairs, we do have some historical precedents for US stocks and implied volatility moving higher in tandem. John Kolovos, chief technical strategist at Macro Risk Advisors, likened the current setup in stocks to the mid-’90s, when Federal Reserve interest-rate cuts helped the economy achieve a soft landing and the S&P 500 and the VIX Index proceeded to trend upward.

“I remember this old saying: you can have a low-vol bull market, you can have a high-vol bull market, but you can never have a low-vol bear market,” he said.

More Markets

See all Markets
markets

FDA says it will take “decisive steps” against GLP-1 compounders, HHS refers Hims to DOJ for investigation

The Food and Drug Administration said it would take "decisive steps" to restrict GLP-1 compounding, a day after Hims & Hers announced that it would sell copies ofNovo Nordisk’sWegovy pill.

The FDA specifically called out Hims in the announcement. Additionally, Department of Health and Human Services' General Counsel Mike Stuart said in a post on X on Friday he has referred Hims to the Department of Justice "for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions."

In a statement, Hims said the company "has always operated with a deep commitment to the safety and best interests of consumers and in compliance with applicable law."

"We have a long history of successfully working with regulators, and look forward to continuing to engage with the FDA to ensure safe access to affordable healthcare," they said.

This marks a significant shift in tone from the FDA, which has done little to prevent companies like Hims from marketing copies of Novo's lucrative weight loss drugs.

Shares of Hims fell 14% after hours. The stock had already taken a hit after FDA Commissioner Marty Makary said in an X post on Thursday that the agency would “take swift action against companies mass-marketing illegal copycat drugs.”

The FDA specifically called out Hims in the announcement. Additionally, Department of Health and Human Services' General Counsel Mike Stuart said in a post on X on Friday he has referred Hims to the Department of Justice "for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions."

In a statement, Hims said the company "has always operated with a deep commitment to the safety and best interests of consumers and in compliance with applicable law."

"We have a long history of successfully working with regulators, and look forward to continuing to engage with the FDA to ensure safe access to affordable healthcare," they said.

This marks a significant shift in tone from the FDA, which has done little to prevent companies like Hims from marketing copies of Novo's lucrative weight loss drugs.

Shares of Hims fell 14% after hours. The stock had already taken a hit after FDA Commissioner Marty Makary said in an X post on Thursday that the agency would “take swift action against companies mass-marketing illegal copycat drugs.”

Airlines rise, continuing their volatile 2026, as US-Iran talks may foreshadow some oil supply relief

Airline stocks are surging on Friday, as the market appears to be pricing in some medium-term oil pricing relief following talks between the US and Iran. Iranian officials referred to the meeting as “a good beginning.”

Shares of budget carriers, which have tighter margins and are more sensitive to fluctuations in fuel costs, are leading the surge. Frontier Airlines and Allegiant up more than 13%, while major airlines like United Airlines, American Airlines, and Delta Air Lines are also up at least 6%. JetBlue and Alaska Air are similarly up about 6%.

The market more broadly is rebounding on Friday, with the S&P 500 up 1.6% and bitcoin recovering some of this week’s losses.

Airlines have been volatile to start 2026 amid geopolitical tensions, varying annual forecasts, and the impact of winter storms.

markets
Luke Kawa

The AI supply chain is soaring thanks to Amazon’s capex budget

If tech companies are going to spend way more than expected on capex, well, that means other companies are poised to benefit from that massive spending spree.

Amazon’s plan for $200 billion in business investment this year was the exclamation point to end a reporting period that saw every Magnificent 7 hyperscaler that provides guidance offer a 2026 capex budget well above what Wall Street had anticipated.

Here’s a look at the different parts of the supply chain that are soaring on the persistent demand for, and seeming scarcity of, AI compute:

Here’s a look at the different parts of the supply chain that are soaring on the persistent demand for, and seeming scarcity of, AI compute:

markets

For memory chips, the “parabolic price hike” is continuing to ramp higher

The remarkable run-up in prices for memory chips continued into early February, analysts at Bernstein Research say, driven largely by data center demand from hyperscalers and cloud service providers (CSP).

Prices for NAND flash memory wafers — a type of memory used in devices, as it retains data even when powered down — soared 35% between the end of 2025 and February 2.

Spot prices for DRAM — ubiquitous short-term data storage chips — jumped about 28% in that period. But that massively understates the remarkable shift in pricing for what were long seen as commodity tech hardware inputs. DRAM prices are more than 2,000% over the last year, while NAND prices are up more than 600% in that period.

The ongoing momentum provides still more support for memory chip plays like Micron and Sandisk, which have been big market winners in recent months.

In a note published earlier this week, Bernstein Research analysts wrote:

“The parabolic price hike continued in Jan. Indicated price increase for 1QCY26 is much stronger than we expected and we hence see upside to our near term memory pricing projection. Unrelenting CSP demand remained the main driver. PC and Mobile demand hasn’t been destroyed yet because of lean inventory & pull-forward purchase. Going forward price hike is expected to continue but likely at a slower rate, as PC and Mobile demand should contract meaningfully this year. Price however may stay elevated throughout this year, supported by CSP demand.”

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.